Melinta Therapeutics, LLC drugs
5 results
Baxdela (delafloxacin meglumine)
(delafloxacin meglumine)Melinta Therapeutics, LLC
Usage: BAXDELA is indicated for treating acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) in adults caused by specific susceptible bacteria, including MRSA and MSSA. It should be used judiciously to prevent drug resistance and based on culture and susceptibility data when available.
Kimyrsa (oritavancin diphosphate)
(oritavancin diphosphate)Melinta Therapeutics, LLC
Usage: KIMYRSA® is indicated for treating acute bacterial skin and skin structure infections (ABSSSI) in adults caused by specific Gram-positive bacteria, including methicillin-susceptible and resistant Staphylococcus aureus, as well as other susceptible Streptococcus and Enterococcus species. It should be used judiciously to prevent antibiotic resistance.
Orbactiv (oritavancin)
(oritavancin)Melinta Therapeutics, LLC
Usage: ORBACTIV® (oritavancin) is indicated for treating adults with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus and various Streptococcus species. It should be used judiciously to prevent drug resistance.
Rezzayo (rezafungin)
(rezafungin)Melinta Therapeutics, LLC
Usage: REZZAYO is indicated for patients aged 18 or older with limited treatment options for candidemia and invasive candidiasis. It has not been studied for endocarditis, osteomyelitis, or meningitis due to Candida. Initiate therapy before culture results but adjust as needed once results are available.
Vabomere (meropenem-vaborbactam)
(Meropenem-Vaborbactam)Melinta Therapeutics, LLC
Usage: VABOMERE® is indicated for treating complicated urinary tract infections, including pyelonephritis, in adults caused by susceptible microorganisms such as E. coli, Klebsiella pneumoniae, and Enterobacter cloacae. It should be used to prevent drug-resistant bacteria and informed by culture and susceptibility data when available.